Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Justin W Ady, Jacqueline Heffner, Elizabeth Klein & Yuman Fong. (2014) Oncolytic viral therapy for pancreatic cancer: current research and future directions. Oncolytic Virotherapy 3, pages 35-46.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now
Read now
Janet Plate. (2011) Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Review of Vaccines 10:6, pages 825-836.
Read now
Read now
Michael A Morse, Joseph Robert Hall & Janet MD Plate. (2009) Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer. Expert Opinion on Biological Therapy 9:3, pages 331-339.
Read now
Read now
Philippe Fournier & Volker Schirrmacher. (2009) Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. Expert Review of Vaccines 8:1, pages 51-66.
Read now
Read now
Vincent G Brichard & Diane Lejeune. (2008) Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opinion on Biological Therapy 8:7, pages 951-968.
Read now
Read now
Andreas Hilbig & Helmut Oettle. (2008) Gemcitabine in the treatment of metastatic pancreatic cancer. Expert Review of Anticancer Therapy 8:4, pages 511-523.
Read now
Read now
Marianne M Stanford & Grant McFadden. (2007) Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opinion on Biological Therapy 7:9, pages 1415-1425.
Read now
Read now
Ravi A Madan, Philip M Arlen & James L Gulley. (2007) PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma. Expert Opinion on Biological Therapy 7:4, pages 543-554.
Read now
Read now
Articles from other publishers (39)
Suresh Sulekha Dhanisha & Chandrasekharan Guruvayoorappan. (2023) Pathological Implications of Mucin Signaling in Metastasis. Current Cancer Drug Targets 23:8, pages 585-602.
Crossref
Crossref
Kenneth Lundstrom. (2023) Gene Therapy Cargoes Based on Viral Vector Delivery. Current Gene Therapy 23:2, pages 111-134.
Crossref
Crossref
Kenneth Lundstrom. (2023) Viral Vectors in Gene Therapy: Where Do We Stand in 2023?. Viruses 15:3, pages 698.
Crossref
Crossref
Susanne Deininger, Peter Törzsök, Michael Mitterberger, Maximilian Pallauf, David Oswald, Christian Deininger & Lukas Lusuardi. (2022) From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC). Cancers 14:3, pages 694.
Crossref
Crossref
Kenneth Lundstrom. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
28
.
Ban Qi Tay, Quentin Wright, Rahul Ladwa, Christopher Perry, Graham Leggatt, Fiona Simpson, James W. Wells, Benedict J. Panizza, Ian H. Frazer & Jazmina L. G. Cruz. (2021) Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions. Vaccines 9:5, pages 535.
Crossref
Crossref
James E. Talmadge & Kenneth H. Cowan. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
470
485.e5
.
Mohit Gupta, Max Kates & Trinity J. Bivalacqua. (2019) Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments. Current Opinion in Oncology 31:3, pages 183-187.
Crossref
Crossref
Kenneth Lundstrom. (2019) Gene Therapy Today and Tomorrow. Diseases 7:2, pages 37.
Crossref
Crossref
Sant P. Chawla, Howard Bruckner, Michael A. Morse, Nupur Assudani, Frederick L. Hall & Erlinda M. Gordon. (2019) A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer. Molecular Therapy - Oncolytics 12, pages 56-67.
Crossref
Crossref
Kenneth Lundstrom. (2018) Viral Vectors in Gene Therapy. Diseases 6:2, pages 42.
Crossref
Crossref
Medea Neek, Jo Anne Tucker, Tae Il Kim, Nicholas M. Molino, Edward L. Nelson & Szu-Wen Wang. (2018) Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. Biomaterials 156, pages 194-203.
Crossref
Crossref
Nicholas M. Donin, Andrew T. Lenis, Stuart Holden, Alexandra Drakaki, Allan Pantuck, Arie Belldegrun & Karim Chamie. (2017) Immunotherapy for the Treatment of Urothelial Carcinoma. Journal of Urology 197:1, pages 14-22.
Crossref
Crossref
Paul R. Kunk, Todd W. Bauer, Craig L. Slingluff & Osama E. Rahma. (2016) From bench to bedside a comprehensive review of pancreatic cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Andrea Marie Ibrahim. (2016) Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World Journal of Gastroenterology 22:2, pages 748.
Crossref
Crossref
Manzoor M KhanManzoor M. Khan. 2016. Immunopharmacology. Immunopharmacology
363
396
.
Chadwan Al Yaghchi, Zhongxian Zhang, Ghassan Alusi, Nicholas R Lemoine & Yaohe Wang. (2015) Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy 7:12, pages 1249-1258.
Crossref
Crossref
Si-Xue Liu. (2014) Gene therapy in pancreatic cancer. World Journal of Gastroenterology 20:37, pages 13343.
Crossref
Crossref
James E. Talmadge & Kenneth H. Cowan. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
493
507.e4
.
Christiaan R. de Vries, Elizabeth Poplin, Robert E. Weiss, David A. August, Emmanuel Gabriel, Robert S. DiPaola & Edmund C. Lattime. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
241
257
.
. (2013) . Nippon Jibiinkoka Gakkai Kaiho 116:5, pages 573-580.
Crossref
Crossref
Sebastian Dempe, Muriel Lavie, Sofie Struyf, Rauf Bhat, Hannelien Verbeke, Stephanie Paschek, Nele Berghmans, Renate Geibig, Jean Rommelaere, Jo Van Damme & Christiane Dinsart. (2012) Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment. Cancer Immunology, Immunotherapy 61:11, pages 2113-2123.
Crossref
Crossref
Michael A. Skinner & Stephen M. Laidlaw. 2012. Vaccinology. Vaccinology
237
254
.
Jane E. Schrimpf, Eleain M. Tu, Hong Wang, Yee M. Wong & Lynda A. Morrison. (2011) B7 Costimulation Molecules Encoded by Replication-Defective, vhs-Deficient HSV-1 Improve Vaccine-Induced Protection against Corneal Disease. PLoS ONE 6:8, pages e22772.
Crossref
Crossref
Sonia Wennier, Shoudong Li & Grant McFadden. (2011) Oncolytic virotherapy for pancreatic cancer. Expert Reviews in Molecular Medicine 13.
Crossref
Crossref
Sri P. Vagvala, Lydia G. Thebeau, Saydra R. Wilson & Lynda A. Morrison. (2009) Virus-Encoded B7-2 Costimulation Molecules Enhance the Protective Capacity of a Replication-Defective Herpes Simplex Virus Type 2 Vaccine in Immunocompetent Mice. Journal of Virology 83:2, pages 953-960.
Crossref
Crossref
Matthew McKinney & Michael A. Morse. (2008) Advances in immunotherapy for colorectal malignancies. Current Colorectal Cancer Reports 4:4, pages 177-183.
Crossref
Crossref
Daniel Albo, Buckminster Farrow & David H. Berger. (2008) Translation of Recent Advances and Discoveries in Molecular Biology and Immunology in the Diagnosis and Treatment of Pancreatic Cancer. Surgical Oncology Clinics of North America 17:2, pages 357-376.
Crossref
Crossref
Toshiyoshi Fujiwara & Noriaki Tanaka. (2008) . Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 120:3, pages 321-327.
Crossref
Crossref
Jens Stieler. 2008. Pancreatic Cancer. Pancreatic Cancer
165
177
.
Manzoor M. KhanManzoor M. Khan. 2008. Immunopharmacology. Immunopharmacology
227
252
.
Lydia G. Thebeau, Sri P. Vagvala, Yee M. Wong & Lynda A. Morrison. (2007) B7 Costimulation Molecules Expressed from the Herpes Simplex Virus 2 Genome Rescue Immune Induction in B7-Deficient Mice. Journal of Virology 81:22, pages 12200-12209.
Crossref
Crossref
Janet M.D. Plate. (2007) Current Immunotherapeutic Strategies in Pancreatic Cancer. Surgical Oncology Clinics of North America 16:4, pages 919-943.
Crossref
Crossref
Seunghee Kim-Schulze, Bret Taback & Howard L. Kaufman. (2007) Cytokine Therapy for Cancer. Surgical Oncology Clinics of North America 16:4, pages 793-818.
Crossref
Crossref
Karl Erik Hellstrom & Ingegerd Hellstrom. (2007) Vaccines to treat cancer‐an old approach whose time has arrived. Journal of Cellular Biochemistry 102:2, pages 291-300.
Crossref
Crossref
Lothar H. Finke, Kerry Wentworth, Brent Blumenstein, Natalie S. Rudolph, Hyam Levitsky & Axel Hoos. (2007) Lessons from randomized phase III studies with active cancer immunotherapies – Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC). Vaccine 25, pages B97-B109.
Crossref
Crossref
Richard J. Anderson & Joerg Schneider. (2007) Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine 25, pages B24-B34.
Crossref
Crossref
Markus J.V. Vähä-Koskela, Jari E. Heikkilä & Ari E. Hinkkanen. (2007) Oncolytic viruses in cancer therapy. Cancer Letters 254:2, pages 178-216.
Crossref
Crossref
Richard Harrop, Justin John & Miles W. Carroll. (2006) Recombinant viral vectors: Cancer vaccines. Advanced Drug Delivery Reviews 58:8, pages 931-947.
Crossref
Crossref